EUVIMED · CrossrefZeitschrift
Blood Global Hematology
ISSN 3050-5658 · Elsevier BV
Neueste Artikel
Gene-level kinetics and clonal architecture of measurable residual disease in acute myeloid leukemia
Real-world effectiveness and safety of ruxolitinib in myelofibrosis: a multicenter cohort study (CHART-MF)
Real-world outcomes of pregnancy in chronic myeloid leukemia in a resource-limited setting
Starting from scratch: establishing a cooperative group for adult ALL treatment in Brazil through the Implementation Research Logic Model
Myelofibrosis treatment perspective from Turkey
Improving outcomes of pregnancy in chronic myeloid leukemia
The cell therapy gap in Latin America: barriers, solutions, and a Chilean road map
Challenges of management and outcomes of multiple myeloma in Armenia: A real world experience from a developing country
"Many faces of atypical mononuclear cells: a diagnostic challenge in resource-variable settings"
Commentary on international guidelines for patients with refractory or relapsed diffuse large B-cell lymphoma in the Asia-Pacific region
Clinical practice guidelines for the diagnosis and management of Hodgkin lymphoma in countries with restricted resources
The role of outer setting health system factors in the use of hydroxyurea for Ugandan children with sickle cell anemia
Benefits and perils of generic drugs for hematologic neoplasms and their use in low- and middle-income countries: a narrative review
CAR-T in resource-limited regions
Hodgkin lymphoma treatment patterns and outcome disparities in low- and middle-income countries
Max Access Solutions: an innovative model to bring life-saving medicines to low- and middle-income countries
Racial disparities in multiple myeloma
Hydroxyurea to decrease stroke risk in children with sickle cell anemia: a systematic review and meta-analysis
Comparing the distribution of Hodgkin lymphoma subtypes and survival outcomes between Latin American and US patients
Clinical practice recommendations for myelofibrosis management in Latin America from an expert consensus group
Substantially improved survival for intermediate-risk AML: an Australian statewide network experience spanning 20 years
Allogeneic HSCT in children with relapsed/refractory acute lymphoblastic leukemia: ambulatory or in-hospital?
Impact of socioeconomic status on acute myeloid leukemia outcomes in New Zealand’s universal health care
Latin America and evolving oncotherapeutics using CAR T cells, conjugated antibodies, and bispecific antibodies
Maternal death and postpartum hemorrhage in sub-Saharan Africa: insights from autopsies in Mozambique
Global blood and marrow transplantation training for international physicians from LMICs: 5-year experience at UIC
Impact of resource availability on outcomes of diffuse large B-cell lymphoma: real-world data from Pakistan
Introduction of treatment for children with acute lymphoblastic leukemia in a resource-limited hospital in Cambodia
Report on management approaches and treatment results in chronic myeloid leukemia associated with SARS-CoV-2 infection
Welcome to Blood Global Hematology
EUVIMED